Veloxis Pharmaceuticals A/S (VELO) Establishes a New Warrant Programme
8/22/2013 9:44:42 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
To: NASDAQ OMX Copenhagen A/S -- Today, the Board of Directors of Veloxis has decided to establish a new warrant programme for members of the Board of Directors. Thus, the Board of Directors of the Company has today partly exercised its authorisation pursuant to Section 5A of the Articles of Association.
Help employers find you! Check out all the jobs and post your resume.